MWI Health
MWI Health in Sioux Falls, South Dakota offers Spravato (esketamine) for adults with treatment-resistant depression. This FDA-approved nasal spray works differently than traditional antidepressants by targeting the NMDA receptor and increasing glutamate, often reducing depressive symptoms within hours or days rather than weeks.
As of January 2025, Spravato can be used as a standalone treatment, and it is also indicated for major depressive disorder with suicidal ideation. Treatment is administered in a supervised clinical setting, with patients monitored for at least two hours after each dose and a ride home arranged afterward.
MWI Health pairs Spravato with broader mental health services including psychotherapy and TMS therapy. Sessions typically begin twice weekly before transitioning to a maintenance schedule based on response.
Spravato® (esketamine)
Offered by this practiceUsed for:
Treatment details are based on information published by the clinic, checked in August 2026.
Monday-Friday: 8:00am-5:00pm
Saturday-Sunday: Closed
Accepts insurance
Contact clinic for pricing.
Send your details to MWI Health and they can reach out to you directly.
Is this your clinic?
Keep your clinic information up to date. Claim your free listing to manage your services, pricing, and photos.
Online management is opening gradually. You can still send us corrections for free.
Request a Free Listing UpdateWant more visibility?
Get priority placement and up to five photos with a Featured listing. Featured is paid advertising, not a clinical endorsement.
Get FeaturedThe free Verified badge links to your directory listing. It is separate from paid Featured placement and does not certify clinical quality or ownership.